SKI Market

A+| A| A-|

Indian Indices

Sensex

77,186.87 1.44
( 0.00%)

Global Indices

Nasdaq

52,663.96 134.69
(0.26%)

Dow Jones

7,591.19 26.60
(0.35%)

Hang Seng

66,873.37 -1,878.14
(-2.73%)

Nikkei 225

10,555.24 39.32
(0.37%)

Forex

USD-INR

96.14 0.39
(0.40%)

EUR-INR

109.70 0.52
(0.48%)

GBP-INR

128.61 0.54
(0.42%)

JPY-INR

0.59 0.00
(0.41%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Cipla Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

500087

INE059A01026

423.3622252

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

CIPLA

33.75

116164.12

EPS(TTM)

Face Value()

Div & Yield %

42.61

0.9

Back

hindustan unilever ltd

Jubilant Pharmova consolidated net profit declines 44.60% in the December 2025 quarter

Feb 06,2026

Net profit of Jubilant Pharmova declined 44.60% to Rs 55.90 crore in the quarter ended December 2025 as against Rs 100.90 crore during the previous quarter ended December 2024. Sales rose 16.67% to Rs 2116.10 crore in the quarter ended December 2025 as against Rs 1813.70 crore during the previous quarter ended December 2024.

Particulars	Quarter Ended
	Dec. 2025	Dec. 2024	% Var.
Sales	2116.10	1813.70	17
OPM %	13.68	15.83	-
PBDT	253.80	240.70	5
PBT	133.10	149.40	-11
NP	55.90	100.90	-45

77,186.87 1.44 ( 0.00%)

52,663.96 134.69 (0.26%)

7,591.19 26.60 (0.35%)

66,873.37 -1,878.14 (-2.73%)

10,555.24 39.32 (0.37%)

96.14 0.39 (0.40%)

109.70 0.52 (0.48%)

128.61 0.54 (0.42%)

0.59 0.00 (0.41%)